Haematology Flashcards
what are the two broad causes of coagulopathies
medication
conditions
what are the two main congenital conditions causing coagulopathies
Haemophilia (A and B)
von Willebrand’s disease
name 5 congenital conditions that cause coagulopathies
Haemophilia A and B
Von Willebrands
Bernard Soulier syndrome
Wiscott Aldrich syndrome
Idiopathic thrombocypenic purpura
Ehlers Danlos syndrome
what is haemophilia a and b
A = factor VIII deficency
B = factor IX defiency
what is primary and secondary haemostasis
primary hemostasis makes a weak platelet plug at the injury site while secondary hemostasis makes it strong by generating a fibrin mesh on it
how does haemophilia cause coagulopathies
X linked rcessive mutation
deficient factor IX or VIII both affecting the extrinisc pathway of fibrin formation for secondary haemostasis
primary haemostasis can occur but secondary cannot
no strengthening of platelet clot = increased bleeding
what are some signs and symptoms of haemophilia
Nosebleeds with no cause
Easy bruising - large
Spontaneous gingival bleeding
GI bleeds - blood in urine or stool
Difficult clotting after cuts - very small
Bleeding into joints (haemarthrosis)
Cranial bleeds
what classifications of haemophilia are there and how do we classify(not A and B)
severe = clotting factor < 1% spotaenous bleed
moderate = 2 < clotting factor < 5% may bleed
mild = 6 < clotting factor < 40% bleed after trauma/surgery
carrier = factor level may vary
what percentage in the blood would class as ‘normal range’ for clotting factor VIII and IX
50-100%
what is the first, second and third line treatment for haemophilia
anti-fibrinolytics e.g. tranexamic acid
DDAVP - encourages release of factor VIII and VWBf
Direct factor replacements
why do we try other treatments for haemophilia before using direct factor replacement
they are expensive
over time body may build immunity to the factors
how does tranexamic acid work (2)
Anti-fibrinolytic agent that inhibits the breakdown of fibrin clots
Blocks the binding of plasminogen and plasmin to fibrin therefore preventing fibrinolysis
can a dentist prescribe tranexamic acid and why
no
not in dental BNF
what are the (post) instructions for use of tranexamic acid (5)
Use QDS, start 5-10 minutes post extraction
Rinse with 5mls of 5% solution and hold for 2 mins, then spit
Continue for 5 days
Can be used to soak in absorbent gauze, to provide additional pressure to extraction site
avoid drinking for 1 hour after
what is DDAVP and how does it work
desmopressin
synthetic vasopressin - hormone that reduces urine output
DDAVP stimulates the release of endogenous FVIII and VWF from stores in patients endothelium of blood vessels with mild Haemophilia A and VWD
how is desmopressin given
prescribed by haematologist
nasally, intravenously, or as an oral or sublingual tablet
what are the two functions of VWBf
Promotes platelet aggregation (primary haemostasis)
Carrier protein for factor VIII (secondary haemostasis)
what is type I VWBd (3)
commonest type 80%
autosomal dominant
quantative deficency
how do we treat the most common type of VWBd
80% of people have type I
autosomal dominant
trial of DDAVP desmopressin, if unresponsive then factor substitute
what is type II VWBd
autosomal dominant, 15% of people
qualitative deficiency of VWBf
how do we treat type II VWBd
factor VIII concentrate
what is type III VWBd
severe quantative deficency of VWBf
<1%
autosomal recessive
how dow e treat VWBd type III
factor concentrate
compare type I, II and III VWBd (4)
type I = dominant, 80%, quantitive deficiency, treat DDAVP then factor
type II = dominant, 15%, qualitative deficiency, treat concentrate
type III = recessive, severe, <1%, treat concentrate